Pieper, Claus Christian
Geiger, Sergej
Kupczyk, Patrick
Luetkens, Julian A.
Köster, Thomas
Attenberger, Ulrike I.
Schild, Hans Heinz
Funding for this research was provided by:
Rheinische Friedrich-Wilhelms-Universität Bonn
Article History
Received: 5 November 2022
Accepted: 6 September 2023
First Online: 17 October 2023
Competing interests
: There are no conflicts of interest associated with the submitted work. Financial connections outside the present work: JAL: Speakers Bureau: Philips Healthcare (Netherlands), Bayer Vital (Germany). UIA: Speakers Bureau Siemens Healthineers (Germany). CCP: Speakers Bureau: Philips Healthcare (Netherlands), Bayer Vital (Germany), Guerbet (France), Julius Zorn GmbH (Germany).